Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Hyatt

Anesthesiology Nashua, NH Medical Doctor

NPI 1295799799 CMS profile 104553

17 Riverside St Ste 101, Nashua, NH 03062

Open in the dashboard

General payments

$2,359

53 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Hyatt of Nashua, NH is reported in the CMS Open Payments database as having received $2,359 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $312 7
2024 General $101 3
2023 General $213 4
2022 General $206 3
2021 General $300 6
2020 General $674 17
2019 General $554 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Hyatt
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Joseph Hyatt were reported at $312. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Joseph Hyatt Anesthesiology median Middle half National median
2019 $554 $72 $23–$151 $163
2020 $674 $36 $17–$120 $114
2021 $300 $49 $21–$135 $132
2022 $206 $52 $22–$144 $149
2023 $213 $53 $23–$143 $160
2024 $101 $55 $25–$150 $164
2025 $312 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $1,372 24 payments
  2. Vertiflex, Inc. $293 3 payments
  3. Boston Scientific Corporation $221 10 payments
  4. Painteq LLC $203 2 payments
  5. AbbVie, Inc. $68 2 payments
  6. Medtronic USA, Inc. $52 3 payments
  7. Nevro Corp. $48 2 payments
  8. Saluda Medical Americas, Inc. $36 1 payment
  9. Radius Health, Inc. $22 1 payment
  10. Collegium Pharmaceutical, Inc. $16 1 payment
  11. Other $30 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,208 52 payments
  2. Travel and Lodging $151 1 payment
Products named General payments · program years 2019–2025
  1. Proclaim Family of SCS IPGs $642 9 payments
  2. Superion ISS $293 3 payments
  3. ETERNA Structural Heart $211 4 payments
  4. PAINTEQ $203 2 payments
  5. ETERNA Rapid Diagnostics $144 1 payment
  6. PROCLAIM Neuromodulation $118 2 payments
  7. PRODIGY $113 1 payment
  8. BOTOX $68 2 payments
  9. Senza Spinal Cord Stimulation System $48 2 payments
  10. PROCLAIM Neuromodulation $47 2 payments
  11. Other $473 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

147

Median for Anesthesiology: 322

Drug cost

$1,397

Median for Anesthesiology: $8,738

Branded share of claims

19.7%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 29 $622
Gabapentin Generic 53 $532
Cyclobenzaprine Hcl Generic 12 $127
Meloxicam Generic 53 $117

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$139,662

Of which drugs: $3,210

Medicare patients

339

Average age 73

Services billed

19,416

196 women, 143 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Depression 32%
Diabetes 29%
Ischemic heart disease 21%
Chronic kidney disease 21%
Osteoporosis 16%
Heart failure 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 96 17,324 $1,774
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 49 636 $494
Injection, methylprednisolone acetate, 80 mg J1040 Office 52 63 $484
Injection, methylprednisolone acetate, 40 mg J1030 Office 48 56 $282
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 19 222 $65

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in New Hampshire

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record